U.S. Patent and Trademark Office Releases Novartis's Patent Application for Crystalline Forms of N-[4-(Chlorodifluoromethoxy)Phenyl]-6-[(3R)-3-Hydroxypyrrolidin-1-YL]-5-(1H-Pyrazol-5-YL)Pyridine-3-Carboxamide

Published date27 March 2023
Publication titleGlobal IP News (India)
The patent application number is US202217858701 20220706. The patent publication number is US2023089503 (A1). International Patent Classification code is C07D401/14. Cooperative Patent Classification codes are A61K31/4439 (EP, IL, KR), A61K9/0053 (EP, IL), A61K9/20 (IL), A61K9/2018 (EP, IL), A61K9/2095 (EP, IL), A61K9/28 (KR), A61P35/00 (EP, IL, KR), C07D401/14 (EP, IL, KR, US), A61K9/20 (US), C07B2200/13 (IL, KR and US)

According to the abstract released by the U.S. Patent and Trademark Office: "The present invention describes specific crystalline forms of...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT